MAPT and Huntington disease: Elevated Tau levels—presumably reflecting an endogenous protective response, as well as changes in cell volume regulation, and being frequently associated with lower Cre concentrations potentially reflecting reduced energy availability—have been found in HD patients using metabolomic analysis [29] and in other mouse models of HD [26].